• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Strata Skin Sciences

Strata Skin Sciences wins FDA clearance for excimer laser platform

January 24, 2020 By Sean Whooley

Strata Skin Sciences (NSDQ:SSKN) announced that it won FDA 510(k) clearance for its Xtrac Momentum excimer laser system for treating a number of skin diseases. The Xtrac laser is designed to deliver a highly targeted therapeutic beam of UVB light in the treatment of psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma. It is made in three […]

Filed Under: 510(k), Cosmetic/Aesthetic, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA, Strata Skin Sciences

Strata Skin Sciences inks Korea distribution deal

July 8, 2019 By Danielle Kirsh

Strata Skin Sciences (NSDQ:SSKN) today announced a new Korean direct distribution deal with Kosmo Meditech for direct capital sales and direct recurring revenue sales in Korea. Kosmo Meditech has worked with Strata Skin Sciences for more than 13 years. The deal with help strengthen Strata’s Xtrac excimer laser value proposition in Korea and expand its installed […]

Filed Under: Distribution Tagged With: Kosmo Meditech, Strata Skin Sciences

Strata Skin Sciences files motion for contempt against Ra Medical

May 28, 2019 By Fink Densford

Strata Skin Sciences (NSDQ:SSKN) has filed a motion for contempt against Ra Medical (NYSE:RMED) in an ongoing legal battle in which Ra Medical claims Strata and its board chair Uri Geiger made misleading and disparaging statements to financial partners in the time frame surrounding Ra Medical’s initial public offering. In their complaint, Horsham Township, Penn.-based Strata Skin Sciences […]

Filed Under: Business/Financial News, Featured, Legal News Tagged With: Ra Medical, Strata Skin Sciences

Ra Medical files trade libel, settlement breach suit against Strata Skin Sciences

May 17, 2019 By Fink Densford

Ra Medical (NYSE:RMED) said today they filed a suit against Strata Skin Sciences (NSDQ:SSKN) and its board chair Uri Geiger claiming that the parties “undertook a campaign of false, misleading and disparaging statements” to the company’s financial partners before, during and after its initial public offering. The Carlsbad, Calif.-based company said that it filed the complaint in […]

Filed Under: Business/Financial News, Featured, Legal News Tagged With: Ra Medical, Strata Skin Sciences

Strata Skin Sciences adds license for excimer laser vitiligo treatment 

December 11, 2018 By Nancy Crotti

Strata Skin Sciences (NSDQ:SSKN) said it has reached an agreement with an “internationally acclaimed health institution” giving Strata an exclusive license to treat vitiligo using its Xtrac excimer laser. In a novel treatment for vitiligo, the excimer laser incrementally increases the light emitted in the UVB range to restore pigmentation to skin areas affected with […]

Filed Under: Business/Financial News, Cosmetic/Aesthetic Tagged With: Strata Skin Sciences

Strat Skin Sciences wins FDA nod for Multi-Micro Dose excimer laser tip

August 7, 2018 By Fink Densford

Strata Skin Sciences (NSDQ:SSKN) said yesterday it won FDA 510(k) clearance for the Multi-Micro Dose tip designed for use with its Xtrac 308nm excimer laser. The newly cleared tip is indicated for use in conjunction with the Horsham, Penn.-based company’s Xtrac laser system to filter narrow band UVB light at delivery, intended to individualize non-blistering doses […]

Filed Under: 510(k), Cosmetic/Aesthetic, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Strata Skin Sciences

Strata Skin Sciences raises $17m, refreshes exec roster

May 30, 2018 By Fink Densford

Strata Skin Sciences (NSDQ:SSKN) said today it raised $17 million in a new round of financing and announced a number of changes to its executive roster, including an incoming CEO, new board chair and new chief financial officer. The Horsham, Penn.-based company said that the $17 million round of financing was led by Accelmed Growth Partners […]

Filed Under: Business/Financial News Tagged With: Strata Skin Sciences

OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018

May 23, 2018 By Brad Perriello

OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]

Filed Under: Wall Street Beat Tagged With: Clinical Innovations, Dune Medical Devices Inc., Globus Medical, OMNIlife Science Inc., OptiScan, Personnel Moves, SetPoint Medical, Strata Skin Sciences, TrueVision Systems

Strata Skin Sciences raises $17m, taps Rafaeli as CEO

April 2, 2018 By Fink Densford

Strata Skin Sciences (NSDQ:SSKN) said today it raised $17 million in a new round of financing, and that investor Dr. Dolev Rafaeli is slated to take over as interim CEO, with former chief exec Frank McCaney taking the role of interim CFO. In the sale, the Horsham, Penn.-based company said it floated 15.7 million shares of […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Strata Skin Sciences

Strata Skin Sciences to explore ‘strategic alternatives’

December 18, 2017 By Fink Densford

Strata Skin Sciences (NSDQ:SSKN) said today that its board of directors has begun a process to explore and review “strategic alternatives” focused on improving shareholder value, which could include a sale of the company or other transactions. The Horsham, Penn.-based company said that as part of its exploration of strategic alternatives, it is in the process […]

Filed Under: Business/Financial News Tagged With: Strata Skin Sciences

FDA details possible regulatory paths for Strata Sciences Optimal Dosing Tech

September 7, 2017 By Fink Densford

Strata Skin Sciences (NSDQ:SSKN) said this week it received a response letter from the FDA concerning possible 510(k) clearance paths for its Optimal Dosing Technology initially designed for treating psoriasis, vitiligo and other skin conditions. The Horsham, Penn.-based said the federal watchdog proposed 2 alternative paths, the 1st of which would require a clinical trial to […]

Filed Under: 510(k), Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Strata Skin Sciences

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS